TIGENIX SA HEVERLEE ORDINARY SHARES BEL (OTCMKTS:TGXSF) Short Interest Increased By 21.51%

July 14, 2018 - By Mary Gaskins

TiGenix NV (OTCMKTS:TGXSF) Logo

The stock of TIGENIX SA HEVERLEE ORDINARY SHARES BEL (OTCMKTS:TGXSF) registered an increase of 21.51% in short interest. TGXSF’s total short interest was 45,200 shares in July as published by FINRA. Its up 21.51% from 37,200 shares, reported previously. With 900 shares average volume, it will take short sellers 50 days to cover their TGXSF’s short positions. The short interest to TIGENIX SA HEVERLEE ORDINARY SHARES BEL’s float is 0.08%.

It closed at $2.05 lastly. It is down 0.00% since July 14, 2017 and is . It has underperformed by 12.57% the S&P500.

TiGenix NV, a biopharmaceutical company, develops and commercializes therapeutics from its proprietary technology platforms of allogeneic or donor derived stem cells. The company has market cap of $642.39 million. The Company’s stem cell programs are based on proprietary validated platforms of allogeneic expanded stem cells targeting autoimmune, inflammatory, and heart diseases. It currently has negative earnings. The companyÂ’s lead product candidate is the Cx601, which completed Phase III clinical trials for the treatment of complex perianal fistulas in patients suffering from CrohnÂ’s disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.